<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>APOE2 allele &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/apoe2-allele/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 11 Nov 2025 19:06:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>APOE2 allele &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>APOE2 Allele Switch Enhances Alzheimer’s Outcomes in Mice</title>
		<link>https://bioengineer.org/apoe2-allele-switch-enhances-alzheimers-outcomes-in-mice/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 11 Nov 2025 19:06:07 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Amyloid plaque reduction]]></category>
		<category><![CDATA[APOE2 allele]]></category>
		<category><![CDATA[Astrocytes]]></category>
		<category><![CDATA[Late-stage Alzheimer's intervention]]></category>
		<category><![CDATA[Transgenic mouse model]]></category>
		<guid isPermaLink="false">https://bioengineer.org/apoe2-allele-switch-enhances-alzheimers-outcomes-in-mice/</guid>

					<description><![CDATA[In a groundbreaking advancement for Alzheimer’s disease research, scientists have demonstrated that switching the APOE4 gene variant to APOE2 specifically in astrocytes can significantly reduce amyloid plaque burden and enhance certain cognitive functions in a widely used mouse model of Alzheimer’s. This innovative study, published in Nature Neuroscience in 2025, offers promising insights into the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">295047</post-id>	</item>
	</channel>
</rss>
